Clinical trial
Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Chronic Migraine and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (PREDICT)
NCT02502123 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Chronic Migraine and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (PREDICT)
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 2, 2015
- Completion date
- January 29, 2019
- Enrollment
- 215 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.